Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1291)	6/1/1999 7:29:00 PM
From: Benchman	Respond to of 1837

I agree. Not only that, but according to this post on yahoo: "In their earnings warning, AHP made a point of saying that Premarin sales were growing." So even with an overall decline in AHP sales, the estrogen drug market was still expanding. A positive for DRMD. Too bad I don't have anymore cash left, looks like a great opportunity here. B

To: vestor who wrote (1291)	6/2/1999 7:30:00 PM
From: Thure Meyer	Read Replies (1) \| Respond to of 1837

FYI, Patent granted to Duramed on June 1, 1999 United States Patent 5,908,638 Huber , et al. June 1, 1999 Pharmaceutical compositions of conjugated estrogens and methods for their use Abstract This invention relates to novel pharmaceutical compositions and methods for their preparation containing conjugated estrogens for the treatment of peri-menopausal, menopausal and post-menopausal disorders in women. The novel pharmaceutical compositions comprise a carrier base material and conjugated estrogens formed into a solid unit dosage form possessing a regular incremental release of the medicament upon oral administration. Further, the invention comprises the combination of conjugated estrogens with progestogens in a solid, shaped dosage unit. Specifically, the invention comprises the use of an organic excipient such as high molecular weight hydroxyalkyl alkylcelluloses. The use of an organic excipient such as hydroxypropylmethylcellulose in a stable, solid dosage formulation containing either conjugated estrogens alone or in combination with a progestogen is described. Inventors: Huber; Harold Eugene (Cincinnati, OH); Ryan; Mary Katherine (Mainville, OH) Assignee: Duramed Pharmaceuticals, Inc. (Cincinnati, OH) Appl. No.: 690407 Filed: July 25, 1996 Well, all they have to do is sell it and they will have a nice market for the next 17 years. Thure